Mark I. Froimson's most recent trade in Pacira BioSciences Inc was a trade of 11,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 20,636 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Purchase of securities on an exchange or from another person at price $ 11.58 per share. | 12 Aug 2024 | 1,400 | 14,473 (0%) | 0% | 11.6 | 16,212 | Common Stock |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 13,073 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,925 | 12,925 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,775 | 7,843 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 1,160 | 6,068 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Sale of securities on an exchange or to another person at price $ 59.37 per share. | 09 May 2022 | 1,000 | 4,908 (0%) | 0% | 59.4 | 59,370 | Common Stock |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Dec 2021 | 400 | 5,908 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Mark I. Froimson | Director | Sale of securities on an exchange or to another person at price $ 72.26 per share. | 15 Mar 2021 | 734 | 5,242 (0%) | 0% | 72.3 | 53,039 | Common Stock |